Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroblastoma-amplified gene protein (NBAS) is a large, highly conserved peripheral membrane protein and a subunit of the NRZ tethering complex, which bridges SNARE complexes and coordinates Golgi-to-endoplasmic reticulum (ER) retrograde transport. NBAS is essential for vesicle tethering, SNARE assembly, and cellular homeostasis. Mutations in the NBAS gene cause diverse multisystem disorders, most notably infantile liver failure syndrome and immunodeficiency. NBAS is also implicated in neuroblastoma due to frequent gene amplification. Further, NBAS is involved in cell cycle checks, autophagy, glycosylation, and the nonsense-mediated mRNA decay pathway. Current drug discovery efforts focus on identifying ligands for NBAS and exploring its druggability, but no direct therapeutic agents are yet clinically validated[1][2][3][4][6].
Not available; no clinically approved drugs act directly on NBAS. Most mechanism data relates to its molecular roles in vesicle tethering and SNARE complex regulation[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroblastoma-amplified gene protein (NBAS) (NBAS).